Performance of an Investigational Blood Glucose Monitoring System in a Clinical Setting
Clinical Trial Protocol for NINJA 2 System With CONTOUR Sensor
1 other identifier
interventional
98
1 country
1
Brief Summary
The purpose of this study is to evaluate the performance of an investigational blood glucose meter with the Contour sensor strip. It was decided that this investigational monitoring system would not be part of a regulatory submission and it will not proceed to marketed product.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable diabetes
Started Dec 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedFirst Submitted
Initial submission to the registry
December 29, 2010
CompletedFirst Posted
Study publicly available on registry
December 31, 2010
CompletedResults Posted
Study results publicly available
October 16, 2012
CompletedNovember 3, 2016
September 1, 2016
Same day
December 29, 2010
September 14, 2012
September 28, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Numbers of Fingerstick Blood Glucose (BG) Results Within +/- 5 to 15mg/dL (<75 mg/dL) or Within +/- 5% to 20% (>=75 mg/dL) of Laboratory Glucose Method
Subjects with diabetes tested subject fingerstick blood using an investigational blood glucose meter (BGM). BGM results were compared to a reference lab glucose method - Yellow Springs Instrument (YSI) Analyzer. BG results were used to calculate the number of BG results within +/- 5 to 15 mg/dL (for reference BG results \<75mg/dL) or +/- 5 to 20% (for reference BG results \>=75mg/dL) of the reference method results.
2 hours
Secondary Outcomes (3)
Numbers of Palm Blood Glucose (BG) Results Within +/- 5 to 15 mg/dL (<75 mg/dL) or Within +/- 5% to 20% (>=75 mg/dL) of Laboratory Glucose Method
2 hours
Number of Subjects Rated as<=3 Performing Basic Meter Tasks (Labeling Comprehension)
2 hours
Numbers of Forearm Blood Glucose (BG) Results Within +/- 5 to 15 mg/dL (<75 mg/dL) or Within +/- 5% to 20% (>=75 mg/dL) of Laboratory Glucose Method
2 hours
Study Arms (1)
Intended Users of the System
EXPERIMENTALUntrained subjects with diabetes obtained capillary fingerstick, palm, and forearm blood and performed Blood Glucose (BG) tests using a Ninja 2 investigational blood glucose meter and the Contour® sensor. This BG monitoring system will not proceed to marketed product.
Interventions
Untrained subjects with diabetes performed Blood Glucose(BG) tests from the subject's capillary blood obtained from fingerstick, palm, and forearm using the Ninja 2 investigational meter. All BG results were compared to a reference laboratory glucose method. Subjects' success at performing basic tasks using only the User Guide were rated by study staff.
Eligibility Criteria
You may qualify if:
- Males and females, 18 years of age and above
- Type 1 or type 2 diabetes
- Currently self-testing blood glucose at home at least twice daily
- Able to speak, read, and understand English
- Willing to complete all study procedures
You may not qualify if:
- Currently Pregnant
- Hemophilia or any other bleeding disorder
- Employee of competitive medical device company
- Cognitive disorder or other condition which, in the opinion of the investigator, would put the person at risk or seriously compromise the integrity of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Consumer Product Testing Company
Fairfield, New Jersey, 07004, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
It was decided that this investigational BG monitoring system would not be part of a regulatory submission. It will not proceed to market.
Results Point of Contact
- Title
- Carmine Greene, Senior Clinical Research Scientist
- Organization
- Ascensia Diabetes Care
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Caswell, PhD
Consumer Product Testing Company
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- GT60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 29, 2010
First Posted
December 31, 2010
Study Start
December 1, 2010
Primary Completion
December 1, 2010
Study Completion
December 1, 2010
Last Updated
November 3, 2016
Results First Posted
October 16, 2012
Record last verified: 2016-09